Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SoftOx Solutions AS Capital/Financing Update 2023

Mar 27, 2023

3747_iss_2023-03-27_46a19337-5da2-4a70-aa0c-e0579bd1c5b8.html

Capital/Financing Update

Open in viewer

Opens in your device viewer

SoftOx Solutions AS: Restructures to conserve resources while exploring strategic alternatives

SoftOx Solutions AS: Restructures to conserve resources while exploring strategic alternatives

OSLO – March 27, 2023: SoftOx Solutions AS (“SoftOx” or the “Company”) today announces that its Board of Directors has decided to temporarily lay off employees to save costs during a period of financing and restructuring of the Company. As a result of this decision, SoftOx Solutions Denmark has been closed down and key personnel will be reengaged.

During the temporary layoff period, the company will continue the work on securing financing for further development of SoftOx Solutions AS.

For further information, please contact:

Geir Almås, Executive Chairman of SoftOx Solutions AS

Christian Harstad, Interim CEO of SoftOx Solutions AS

Mail: [email protected]

Phone: Front Desk: (+47) 948-59-599

About SoftOx Solutions AS

SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a medtech and clinical-stage pharmaceutical company based in Oslo, Norway, with the goal of reducing the spread of infection and emergence of antimicrobial resistance. For more information on SoftOx, visit www.soft-ox.com